Cicatricial pemphigoid

Journal of the American Academy of Dermatology

Volumn 43, Issue 4, 2000, Pages 571-594

  Fleming, Thomas E ^a   Korman, Neil J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETACAINE; CLOBETASOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; DESOXIMETASONE; DEXAMETHASONE; DIPHENHYDRAMINE; DYCLONINE; FLUOCINONIDE; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENT; LIDOCAINE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; MUCOUS MEMBRANE PEMPHIGOID; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; STAGING;

EID: 0033782171     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.107248     Document Type: Review

References (200)

1. Immune-mediated subepithelial blistering diseases of mucous membranes: Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificities of autoantibodies
2. Antiepiligrin cicatricial pemphigoid: A subepithelial bullous disorder
3. Antiepiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
4. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid
5. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization
6. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid
7. Oral pemphigoid: Subset of cicatricial pemphigoid?
8. Pemphigus of the conjunctiva
9. Cauistische mitteilungen aus fung der conjunctiva
10. Pemphigus of the skin and mucous membranes of the mouth, associated with 'essential shrinking' and pemphigus of the conjunctivae
11. Der chronische schleimhaut-pemphigus der oberen luftwege
12. Le diagnostic des dermatoses bulleuses an laboratorie
13. Pemphigus: A histopathologic study
14. Pemphigus
15. Commentary on Brunsting LA, Perry HO. Benign pemphigoid? A report of seven cases with chronic, scarring, herpetiform plaques about the head and neck
16. Persistent denudation of the scalp in cicatricial pemphigoid: Treatment by skin grafting
17. Cicatricial pemphigoid and skin grafts
18. Benign mucous membrane pemphigoid
19. Cicatricial pemphigoid: Immunofluorescent studies
20. Some unusual findings obtained by the immunofluorescence method in bullous pemphigoid and benign mucous membrane pemphigoid
21. Circulating antibodies in cicatricial pemphigoid
22. Cicatricial pemphigoid: Immunofluorescent studies
23. Ocular cicatricial pemphigoid
24. Cicatricial pemphigoid: Diagnosis and treatment
25. Cicatricial pemphigoid in a young girl
26. Cicatricial pemphigoid in a 4-year-old child
27. Disseminated cicatricial pemphigoid in a child and in an adult: Ultrastructural diagnostic criteria and differential diagnosis with special reference to acquired epidermolysis bullosa
28. Cicatricial pemphigoid in a 6-year-old child: Report of a case and review of the literature
29. Cicatricial pemphigoid
30. Bullous pemphigoid, cicatricial pemphigoid and pemphigus vulgaris: A comparative clinical survey of 278 cases
31. HLA antigens in ocular cicatricial pemphigoid
32. Association of HLA-DR4 with ocular cicatricial pemphigoid
33. Association of autoimmunity and cicatricial pemphigoid: Is there an immunogenetic basis?
34. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid
35. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid
36. High frequency of HLA-DQB1*0301 allele in patients with pure ocular cicatricial pemphigoid
37. Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid
38. Drug-induced pemphigoid: Bullous and cicatricial
39. Induced ocular pseudopemphigoid
40. Idoxuridine-induced conjunctival cicatrization
41. Drug-induced cicatricial pemphigoid affecting the conjunctiva: Light and electron microscopic features
42. Drug-induced cicatrizing conjunctivitis simulating ocular pemphigoid
43. Drug-induced pemphigoid: A spectrum of diseases
44. Drug-induced ocular cicatricial pemphigoid: A series of clinicopathological reports
45. Ocular cicatricial pemphigoid associated with practolol therapy
46. Drug-induced anogenital cicatricial pemphigoid
47. Ocular cicatricial pemphigoid: A case report of monozygotic twins discordant for the disease
48. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome
49. Frequency of desquamative gingivitis in skin diseases
50. Oral involvement in mucous membrane pemphigoid
51. Cicatricial pemphigoid
52. Cicatricial pemphigoid
53. Desquamative gingivitis: Clinical, histopathologic, immunopathologic, and therapeutic observations
54. Cicatricial pemphigoid
55. Ocular pemphigoid
56. Improved detection of disease progression in ocular cicatricial pemphigoid
57. Disseminiertes vernarbendes pemphigoid
58. Disseminiertes vernarbendes pemphigoid
59. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid
60. Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid: Report of a case proved by preembedding immunogold electron microscopy
61. Upper aerodigestive tract manifestations of cicatricial pemphigoid
62. Sore throat, a first symptom in laryngeal cicatricial pemphigoid
63. Oral lesions of mucous membrane pemphigoid
64. Bullous and cicatricial pemphigoid: Clinical, histopathologic, and immunopathologic correlations
65. Benign mucous membrane (cicatricial) pemphigoid revisited: A clinical and immunological reappraisal
66. Benign mucous membrane pemphigus
67. Benign mucous membrane pemphigoid: An unusual case with electron microscopic findings
68. Histochemistry and fine structure of oral lesions of mucous membrane pemphigoid
69. Ocular pemphigus
70. Modern treatment of severe 'shrinkage of the conjunctiva'
71. Benign mucous membrane pemphigoid. 3. Biopsy
72. Scanning electron microscopy of conjunctival surfaces in patients with ocular cicatricial pemphigoid
73. Immunofluorescence studies in mucous membrane pemphigoid
74. Cicatricial pemphigoid: A study of 15 cases
75. Cicatricial pemphigoid of Brunsting-Perry: Immunofluorescent studies
76. Immunopathology of cicatricial pemphigoid: Studies of complement deposition
77. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid
78. Mucosal involvement in bullous and cicatricial pemphigoid: A clinical and immunopathological study
79. Immunofluorescent studies in ocular cicatricial pemphigoid
80. The localization of the bullous pemphigoid and cicatricial pemphigoid antigens: Direct and indirect immunofluorescence of suction blisters
81. Mucous gland basement membrane immunofluorescence in cicatricial pemphigoid
82. Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid
83. Immunohistopathologic testing in patients suspected of ocular cicatricial pemphigoid
84. Autoimmune phenomena in ocular cicatricial pemphigoid
85. Cicatricial pemphigoid with circulating antibasement membrane antibodies
86. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies
87. Cicatricial pemphigoid: Direct and indirect immunofluorescence studies
88. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis
89. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid
90. Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay
91. Immune-mediated subepidermal blistering diseases of the mucous membranes: Improving the detection of circulating autoantibodies by the use of concentrated serum samples
92. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita
93. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: A prospective study of IgG and C3 bound in vivo in 32 patients
94. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane
95. Immunoelectron microscopic findings in cicatricial pemphigoid: Their significance in relation to epidermolysis bullosa acquisita
96. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: A study by indirect immunoelectron microscopy
97. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease
98. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the α subunit of laminin 5
99. Antiepiligrin cicatricial pemphigoid: The first case report from Japan
100. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen
101. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain
102. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida
103. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines
104. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid
105. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting
106. Bullous pemphigoid and cicatricial pemphigoid: Immunoblotting detection of involved autoantigens
107. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid
108. A new nomenclature for the laminins
109. Kalinin: An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments
110. Epiligrin, a new cell adhesion ligand for α3β1 in epithelial basement membranes
111. The α6β4 integrin is a receptor for both laminin and kalinin
112. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor
113. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5
114. A function for the integrin α6β4 in the hemidesmosome
115. Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid
116. Epidermolysis bullosa hereditaria letalis
117. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (laminin 5)
118. Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa
119. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain
120. The role of antibody to human β4 integrin in conjunctival basement membrane separation: Possible in vitro model for ocular cicatricial pemphigoid
121. Costimulatory molecules in ocular cicatricial pemphigoid
122. Bullous pemphigoid
123. Bullous pemphigoid
124. Pathology of pemphigoid
125. Epidermolysis bullosa acquisita: Report of three cases and review of all published cases
126. Epidermolysis bullosa acquisita: A heterogeneous disease
127. Epidermolysis bullosa acquisita: A pemphigoid-like disease
128. Epidermolysis bullosa acquisita
129. Epidermolysis bullosa acquisita
130. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: Diseases of autoimmunity to type VII collagen
131. Oral lesions of epidermolysis bullosa acquisita
132. Severe ocular involvement in a patient with epidermolysis bullosa acquisita
133. Epidermolysis bullosa acquisita in childhood
134. Childhood epidermolysis bullosa acquisita: Report of three cases and review of the literature
135. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
136. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita
137. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen
138. Epitope mapping of type VII collagen: Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa
139. The relationship between linear IgA disease and benign mucous membrane pemphigoid
140. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: A comparative study demonstrating clinical and immunopathologic overlap
141. Linear IgA disease in adults
142. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone
143. A clinicopathological study of mucosal involvement in linear IgA disease
144. Oral manifestations of linear IgA disease
145. Cicatrizing conjunctivitis as a predominant manifestation of linear IgA bullous dermatosis
146. Linear IgA bullous dermatosis: An immunologically defined disease
147. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis
148. Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera
149. 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane
150. Immunoblotting studies of linear IgA disease
151. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults
152. Linear IgA disease: A heterogeneous disease
153. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies
154. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells
155. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2
156. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies
157. Ultrastructural immunogold studies in two cases of linear IgA dermatosis: Are there two distinct types of this disease?
158. Linear IgA bullous dermatosis of adults and children: An immunoelectron microscopic study
159. Cutaneous manifestations of systemic lupus erythematosus
160. Localized linear bullous eruption of systemic lupus erythematosus in a child
161. Bullous systemic lupus erythematosus: Revised criteria for diagnosis
162. Bullous eruption of systemic lupus erythematosus
163. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen
164. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia
165. Paraneoplastic pemphigus: A distinctive autoimmune syndrome
166. Histologic features of paraneoplastic pemphigus
167. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex
168. Identification and partial characterization of a novel 105-kDalton lower lamina lucida antoantigen associated with a novel immune-mediated subepidermal blistering disease
169. A novel 105-kDa lamina lucida autoantigen: Association with bullous pemphigoid
170. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid
171. Management of oral manifestations of mucous membrane pemphigoid
172. Oral insertable prosthetic device as an aid in treating oral ulcers
173. Topical cyclosporine for oral bullous disorders
174. Topical cyclosporin A in the treatment of anterior segment inflammatory disease
175. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone
176. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988
177. Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid
178. Systemic chemotherapy for ocular cicatricial pemphigoid
179. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid
180. Update on the use of cyclophosphamide in the management of pemphigus, bullous pemphigoid and cicatricial pemphigoid
181. Cyclophosphamide induced cystitis and bladder cancer in patients with Wegener Granulomatosis
182. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide
183. Update on the use of azathioprine in the management of pemphigus and bullous pemphigoid
184. Dapsone and sulfapyridine therapy of pemphigoid diseases
185. Sulfapyridine: A new agent for the treatment of ocular cicatricial pemphigoid
186. Minimizing cicatricial pemphigoid orodynia with minocycline
187. Cicatricial pemphigoid treated with intravenous immunoglobulin
188. Treatment of ocular cicatricial pemphigoid with intravenous gammaglobulin
189. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study
190. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid
191. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid: Implications for patient selection and surgical considerations
192. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid
193. Penetrating keratoplasty in cicatrizing conjunctival diseases
194. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome
195. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid
196. Progression of disease in ocular cicatricial pemphigoid
197. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease
198. Cicatricial pemphigoid: Serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity